Fund Holdings — Checkpoint Capital L.P.

Total Portfolio Value:
$315.63M
Total Bought:
$63.81M
Total Sold:
$39.89M
Net Transaction:
+$23.91M
Notable People:
Tony Michael Berta
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
argenx SEADR(ARGX)150,000142,000-8,000$110.63M$119.41M37.83%+$8.78M
Rhythm Pharmaceuticals, Inc.(RYTM)763,707992,200+228,493$77.13M$106.21M33.65%+$29.08M
Disc Medicine, Inc.(IRON)430,000452,992+22,992$28.41M$35.97M11.40%+$7.56M
Revolution Medicines, Inc.(RVMD)492,300370,000-122,300$22.99M$29.47M9.34%+$6.48M
Corcept Therapeutics Incorporated(CORT)392,331401,395+9,064$32.61M$13.97M4.43%-$18.64M
Cytokinetics, Incorporated(CYTK)37,587166,823+129,236$2.07M$10.60M3.36%+$8.53M
Crinetics Pharmaceuticals In260,0000-260,000$10.83M$0—-$10.83M
Kymera Therapeutics, Inc.(KYMR)61,7500-61,750$3.50M$0—-$3.50M
Septerna, Inc.(SEPN)283,1580-283,158$5.33M$0—-$5.33M
Stoke Therapeutics, Inc.(STOK)212,0490-212,049$4.98M$0—-$4.98M
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q4 2025 | TickerTrail